The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study

BACKGROUND: International guidelines, including NICE, recommend using the 21-gene Recurrence Score assay for guiding adjuvant treatment decisions in ER+, HER2-negative early breast cancer (BC). We investigated the impact of adding this assay to standard pathological tests on clinicians'/patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Kuchel, Anna, Robinson, Tim, Comins, Charles, Shere, Mike, Varughese, Mohini, Sparrow, Geoff, Sahu, Ajay, Saunders, Louise, Bahl, Amit, Cawthorn, Simon J, Braybrooke, Jeremy P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984867/
https://ncbi.nlm.nih.gov/pubmed/26954715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.48
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados